R O Robinson|S Hodgson - JoVE Visualize

Showing results (281-290 of 290) with videos related to

Pageof 29

Sort By:

You have reached the last page of results.This site can display upto 290 results.

Human Molecular Genetics|November 13, 1998

Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of casesR Houlston, S Bevan, A Williams, et al.

Journal of Medical Genetics|March 1, 2007

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)H F A Vasen, G Möslein, A Alonso, et al.

Journal of Medical Genetics|February 25, 1998

Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3S Olschwang, D Markie, S Seal, et al.

Oral Oncology|May 10, 2005

Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neckS Jefferies, Z Kote-Jarai, D Goldgar, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002

Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomasO M Sieber, H Lamlum, M D Crabtree, et al.

Gut|January 16, 2008

Guidelines for the clinical management of familial adenomatous polyposis (FAP)H F A Vasen, G Möslein, A Alonso, et al.

Familial Cancer|September 19, 2009

Recommendations to improve identification of hereditary and familial colorectal cancer in EuropeH F A Vasen, G Möslein, A Alonso, et al.

BJU International|September 16, 2010

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.

Nature|July 3, 1986

Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophyL M Kunkel, J F Hejtmancik, C T Caskey, et al.

British Journal of Cancer|November 19, 2009

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)A Osorio, R L Milne, G Pita, et al.

Pageof 29

Showing results (281-290 of 290) with videos related to

Sort By:

Pageof 29

You have reached the last page of results.This site can display upto 290 results.

Human Molecular Genetics|November 13, 1998

Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of casesR Houlston, S Bevan, A Williams, et al.

Journal of Medical Genetics|March 1, 2007

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)H F A Vasen, G Möslein, A Alonso, et al.

Journal of Medical Genetics|February 25, 1998

Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3S Olschwang, D Markie, S Seal, et al.

Oral Oncology|May 10, 2005

Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neckS Jefferies, Z Kote-Jarai, D Goldgar, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002

Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomasO M Sieber, H Lamlum, M D Crabtree, et al.

Gut|January 16, 2008

Guidelines for the clinical management of familial adenomatous polyposis (FAP)H F A Vasen, G Möslein, A Alonso, et al.

Familial Cancer|September 19, 2009

Recommendations to improve identification of hereditary and familial colorectal cancer in EuropeH F A Vasen, G Möslein, A Alonso, et al.

BJU International|September 16, 2010

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.

Nature|July 3, 1986

Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophyL M Kunkel, J F Hejtmancik, C T Caskey, et al.

British Journal of Cancer|November 19, 2009

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)A Osorio, R L Milne, G Pita, et al.

Pageof 29